NexLife

If your compounded semaglutide provider shut down, you should move to a telehealth provider that uses a licensed 503B compounding pharmacy to ensure medication safety and continuity. Top recommended options for 2026 include: Provider Best For Key Feature Starting Price Ro Body Pharmacy quality In-house 503B compounding ~$199/mo [1][6] FormBlends Physician oversight Transparent 503B sourcing, widest concentrations Competitive [1][6] Henry Meds Budget Lowest-cost transparent option ~$197/mo (12-mo plan) [1][7] Hims/Hers Speed Ships within 24–48 hours Competitive [1][6] NexLife Long-term value Flat $145/mo (12-mo plan), six disclosed partner pharmacies $145/mo [5] Critical safety criteria to verify before switching: Ensure the provider uses a 503B-certified pharmacy (outsourcing facility with FDA oversight), as compounded semaglutide is not FDA-approved and safety varies significantly [1][2][14]. Confirm the pharmacy is accredited (e.g., by Pharmacy Compounding Accreditation Board) and has a verifiable U.S. physical address and licensed pharmacist contact [14]. Avoid providers offering unrealistic promises or skipping medical-history verification [3]. Check state availability: Some providers (like Ally) do not ship to AL, AR, CA, NV, LA, MS, or DC [13]. Additional considerations: The FDA resolved the Ozempic/Wegovy shortage as of February 2025 and approved Wegovy pills in January 2026, so FDA-approved Wegovy or Ozempic from a local pharmacy may be safer and more cost-effective if you can access them [14]. If you prefer lower-cost community options, Reddit users recommend OrderlyMeds ($249/mo all doses, free telehealth), Brello Health ($133/mo), and Pomegranate Health ($100–$133/mo), but verify their pharmacy accreditation independently [8][9][11][15]. Start by contacting Ro Body or FormBlends for the highest safety standards, or NexLife/Henry Meds if budget is the priority [1][5]. Always confirm your state’s eligibility before enrolling.

Mentioned in position 5 of 9